Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer
Academia Oncology · 27.03.2026 · 3 (1)
DOI: 10.20935/acadonco8189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academia Oncology, online erschienen am 27.03.2026. Verfasst von Rui Wu und 2 weiteren Autor:innen. Die Arbeit nennt 124 Literaturangaben.
Abstract (Originalsprache)
Introduction: Ovarian cancer is a leading cause of gynaecological cancer mortality. Ca125, the most widely used serum biomarker, has limited sensitivity for early-stage and type I tumours, prompting evaluation of additional blood-based markers. This umbrella review assesses the diagnostic and prognostic performance of serum and blood biomarkers in ovarian cancer.
Zitieren
APA
Wu, R., Zachou, G., & Michael, A. (2026). Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer. Academia Oncology, 3(1). https://doi.org/10.20935/acadonco8189
Vancouver
Wu R, Zachou G, Michael A. Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer. Academia Oncology. 2026;3(1). doi:10.20935/acadonco8189
BibTeX
@article{Wu2026,
author = {Wu, Rui and Zachou, Georgia and Michael, Agnieszka},
title = {Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer},
journal = {Academia Oncology},
year = {2026},
volume = {3},
number = {1},
doi = {10.20935/acadonco8189}
}
EUVIMED